应用BioFire FilmArray血培养鉴定面板快速鉴定呼吸机相关性肺炎病原体
在国际多中心临床试验MagicBullet框架下,收集西班牙、希腊和意大利32家医院165例疑似VAP患者的呼吸道样本,用BCID面板鉴定病原体并与常规方法比较。BCID面板对主要革兰阴性菌总体特异性98.1%、阴性预测值96.6%、敏感性78.6%、阳性预测值87.3%,1小时出结果。作者认为BCID面板可能有助于快速排除VAP病原体。
要点
- BCID面板对VAP主要病原体总体特异性98.1%、阴性预测值96.6%。
- BCID面板总体敏感性78.6%、阳性预测值87.3%。
- BCID面板直接从呼吸道样本1小时出结果。
核心结论
- BCID面板可能有助于快速排除引起VAP的微生物,尤其是多重耐药革兰阴性菌,从而促进经验性治疗的优化。
研究设计与样本
- 国际多中心临床试验MagicBullet框架下,从西班牙、希腊和意大利32家参与医院的165例疑似VAP患者采集呼吸道样本。
- 用BCID面板鉴定微生物,并与常规微生物学技术结果比较。
主要发现
- 铜绿假单胞菌、鲍曼不动杆菌和肺炎克雷伯菌是最常鉴定的菌种,占微生物的54.7%(70/128)。
- BCID面板对这些微生物的总体特异性为98.1%(95%CI 96-100),阴性预测值为96.6%。
- BCID面板对这些微生物的总体敏感性为78.6%(95%CI 70-88),阳性预测值为87.3%。
- BCID面板直接从呼吸道样本出结果仅需1小时,样本处理时间极少。
关键数值与推荐
- BCID面板对VAP主要病原体的总体特异性98.1%(95%CI 96-100)。
- BCID面板对VAP主要病原体的总体敏感性78.6%(95%CI 70-88)。
- BCID面板对VAP主要病原体的阴性预测值96.6%,阳性预测值87.3%。
临床怎么用
- 作者认为BCID面板可能有助于快速排除引起VAP的微生物,尤其是多重耐药革兰阴性菌。
- 作者认为这可能促进经验性治疗的优化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the ability of the BioFire FilmArray Blood Culture Identification (BCID) panel to rapidly detect pathogens producing late-onset ventilator-associated pneumonia (VAP), a severe infection often produced by Gram-negative bacteria. These microorganisms are frequently multidrug resistant and typically require broad-spectrum empiric treatment. METHODS: In the context of an international multicentre clinical trial (MagicBullet), respiratory samples were collected at the time of suspicion of VAP from 165 patients in 32 participating hospitals in Spain, Greece and Italy. Microorganisms were identified using the BCID panel and compared with results obtained by conventional microbiologic techniques. RESULTS: Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae were the most commonly identified species, representing 54.7% (70/128) of microorganisms. The BCID panel showed high global specificity (98.1%; 95% confidence interval, 96-100) and negative predictive values (96.6%) and a global sensitivity and positive predictive value of 78.6% (95% confidence interval, 70-88) and 87.3%, respectively, for these microorganisms. Importantly, the BCID panel provided results in only 1 hour directly from respiratory samples with minimal sample processing times. CONCLUSIONS: The BCID panel may have clinical utility in rapidly ruling out microorganisms causing VAP, specifically multidrug-resistant Gram-negative species. This could facilitate the optimization of empiric treatment.
引用
- Pulido MR, Moreno-Martínez P, González-Galán V, et al. Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia. Clin Microbiol Infect. 2018. PMID: 29906599. doi:10.1016/j.cmi.2018.06.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。